Research Article
Intravitreal Injections for Macular Edema Secondary to Retinal Vein Occlusion: Long-Term Functional and Anatomic Outcomes
Table 3
Mean visual and anatomic outcomes at each time point in BRVO versus CRVO eyes.
| | | | BRVO | CRVO | value |
| | Baseline | Number of eyes | 124 | 99 | | | BCVAlogMar-mean-(SD) | 0.60 (0.53) | 1.03 (0.84) | <0.0001 | | CMTμm-mean-(SD) | 536.9 (212.5) | 714.4 (275.4) | <0.0001 |
| | 1 year | Number of eyes | 124 | 99 | | | BCVAlogMar-mean-(SD) | 0.43 (0.51) | 0.88 (0.08) | <0.0001 | | CMTμm-mean-(SD) | 355.2 (135) | 458.5 (218.3) | <0.0001 |
| | 2 years | Number of eyes | 114 | 75 | | | BCVAlogMar-mean-(SD) | 0.40 (0.47) | 0.99 (0.85) | <0.0001 | | CMTμm-mean-(SD) | 348.7 (139.7) | 418.1 (203.9) | 0.0057 |
| | 3 years | Number of eyes | 94 | 53 | | | BCVAlogMar-mean-(SD) | 0.47 (0.55) | 0.96 (0.89) | 0.0003 | | CMTμm-mean-(SD) | 337.9 (147.9) | 419.9 (197.3) | 0.0052 |
| | 4 years | Number of eyes | 73 | 42 | | | BCVAlogMar-mean-(SD) | 0.39 (0.48) | 0.96 (0.97) | 0.0004 | | CMTμm-mean-(SD) | 340.8 (158.6) | 449 (236.2) | 0.006 |
| | 5 years | Number of eyes | 52 | 28 | | | BCVAlogMar-mean-(SD) | 0.40 (0.63) | 0.61 (0.59) | 0.0729 | | CMTμm-mean-(SD) | 330.2 (154.3) | 369.8 (159.5) | 0.1426 |
| | 6 years | Number of eyes | 41 | 20 | | | BCVAlogMar-mean-(SD) | 0.32 (0.48) | 0.76 (0.64) | 0.0051 | | CMTμm-mean-(SD) | 313.2 (149.4) | 374.1 (159.4) | 0.0854 |
| | 7 years | Number of eyes | 28 | 11 | | | BCVAlogMar-mean-(SD) | 0.31 (0.45) | 1.20 (1.09) | 0.0098 | | CMTμm-mean-(SD) | 298.5 (159.1) | 334.8 (98.9) | 0.2088 |
| | 8 years | Number of eyes | 16 | 3 | | | BCVAlogMar-mean-(SD) | 0.3 (0.51) | 1.4 (0.98) | 0.0841 | | CMTμm-mean-(SD) | 267.2 (163.5) | 300.5 | 0.1196 |
|
|
